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n.c.bergmann@hotmail.comAbstractThe aim of this study was to test i) whether patients having diabetes and ischemic heart
disease (IHD), i.e., patients suffering from two chronic diseases, demonstrate a higher degree
of chronic stress when compared with patients suffering from IHD alone, and ii) whether
suffering from the two chronic diseases results in an elevation in specific elements of the
chronic stress concept. A total of 361 participants with IHD were included, of whom 47
suffered from concomitant diabetes. Stress was measured by pressure pain sensitivity (PPS)
and by the following questionnaires: the Major Depression Inventory (MDI), the SF-36
Quality of Life questionnaire (SF-36 QOL), the WHO-5 Well-being Index, and the clinical
stress signs (CSSs) scale. Participants with diabetes and IHD had a higher MDI score, a lower
SF-36 physical component summary score, and a lower score of several sub-measurements of
the SF-36 mental component score when compared with patients with IHD without diabetes.
No significant differences were observed regarding stress measured by the PPS measure, the
WHO-5 Well-being Index, or the number of CSSs. In conclusion, the combination of diabetes
and IHD seems to be associated with increased depressive symptoms, lower overall physical
QOL, and reduced mental QOL on several sub-elements of the questionnaire. This should be
recognized in the management of patients with double diagnoses.Key Words
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(2014) 3, 156–160IntroductionThe risk of depression in people with diabetes is two times
higher when compared with patients without diabetes,
and major depression and elevated depressive symptoms
have been found to be present in 11 and 31%,respectively, of individuals suffering from diabetes (1).
The 12-month odds ratio of major depression is also
increased more than twice in outpatients after a
myocardial infarction (MI) (2) and w20% of outpatientssed under a Creative Commons
nported License.
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symptoms (Patient Health Questionnaire R10) (3).
Similarly, psychosocial stress is increased both in patients
with diabetes and in patients with ischemic heart disease
(IHD), and stress is generally accepted to be a risk factor
for a poor outcome in both patient groups (4, 5, 6). The
combination of suffering from both diabetes and IHD is
very common as the presence of diabetes doubles the age-
adjusted risk for cardiovascular disease in men and triples
it in women (7). However, the psychological impact of
suffering from both chronic diseases simultaneously still
needs to be evaluated.
A newly developed handheld device measuring stress-
induced hyperalgesia as pressure pain sensitivity (PPS) has
shown promising results as a new measure of chronic
stress both alone and in combination with a score of
clinical stress signs (CSSs) (8, 9). A high PPS has previously
been found to correlate with well-known stress reactions
such as blood pressure, pulse rate, and work of the heart
in healthy individuals (9), and to correlate with elements
of stress as depressive symptoms, reduced well-being, and
reduced quality of life (QOL) in patients with IHD (8).
Thus, PPS may be used as a semi-objective measure
covering the whole concept of stress.
In this study, we questioned i) whether patients
having both diabetes and IHD, i.e., patients suffering
from two chronic diseases, demonstrate a higher degree
of chronic stress when compared with patients suffering
from IHD alone, as measured by PPS and validated
questionnaires evaluating depressive symptoms, QOL,
psychological well-being, and CSSs, and ii) whether
suffering from the two chronic diseases results in an
elevation in specific elements of the chronic stress concept
when compared with patients suffering solely from IHD.Materials and methods
The materials and methods followed in this study
have been described in detail previously (8). In short,
this was a cross-sectional study of patients with
established and stable IHD. The inclusion criteria were
as follows: established IHD defined as having a previous
MI, or percutaneous coronary intervention, or coronary
artery bypass graft surgery) and having completed
cardiac rehabilitation more than 6 months before
inclusion. The exclusion criteria were as follows: age
over 75 years; suffering from unstable IHD such as
scheduled cardiac surgery or changes in heart medi-
cation within 1 month before inclusion; hospitalization
due to psychiatric disease; and suffering from otherhttp://www.endocrineconnections.org
DOI: 10.1530/EC-14-0083
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Published by Bioscientifica Ltdchronic competing disorders, which clearly impaired the
participant’s QOL.
PPS was measured by an algometric device, which
quantifies the induced sensitivity for pressure experienced
when stressed. The measurement was performed by a
professional instructor after ten minutes of rest in a supine
position on the most sensitive point on the sternum in the
area of IC 4–5 and has been described in detail previously
(8, 9, 10).
The following questionnaires were used for evaluating
the different elements of the chronic stress concept: the
Major Depression Inventory (MDI), which measures
depressive symptoms, with a higher score equaling more
depressive symptoms; the SF-36 Quality of Life
questionnaire (SF-36 QOL), measuring physical and
psychological QOL with a higher score equaling a better
QOL; the WHO-5 Well-being Scale (WHO-5), with a
higher score measuring a higher psychological well-
being; and a newly developed questionnaire, the Clinical
Stress Scale questionnaire, CSS, which includes a score of
56 CSSs experienced during the last 4 weeks, with each
stress sign equaling one point on the scale (8). The
questionnaires were answered on a website established
for the study (www.songheart.org), and each participant
had a personal login, which was first opened after the
study ended in order to avoid bias.
As this study aimed to evaluate the influence on stress
caused by the knowledge of suffering from two chronic
diseases, diabetes was diagnosed based on a self-reported
history, i.e., the knowledge of having diabetes and not on
biochemical cut-off levels.
Participants were recruited from a database on
subjects with established IHD (HjerteRask) at the
Departments of Cardiology at Gentofte and Herlev
University Hospitals, Copenhagen, Denmark. Partici-
pants had been rehabilitated according to the national
guidelines during the period of 1999–2011 and were
recruited to this study between June 2011 and February
2012. Written informed consent was obtained from all
participants and the study was approved by the local
ethical committee and was registered on www.clinical
trials.gov (NCT01513824).Results
A total of 361 participants with IHD were included, of
whom 47 (13%) suffered from known and concomitant
diabetes. Participants with both diabetes and IHD were
comparable to participants with only IHD with respect to
age, sex, and cardiovascular medication except for use ofThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
Table 1 Demographic data in patients with diabetes and
ischemic heart disease (IHD) vs IHD alone.
IHD with
diabetes
(nZ47)
IHD without
diabetes
(nZ314) P value
Men, n (%) 39 (83) 247 (79) NS
Age, mean (S.D.) 64 (6.1) 63 (8.1) NS
b-blockers, n (%) 32 (68) 184 (59) NS
Diuretics, n (%) 19 (40) 89 (28) NS
Cholesterol-lowering
medication, n (%)
40 (85) 279 (89) NS
Angiotensin II receptor
blockers or ACE
inhibitors, n (%)
32 (68) 175 (56) NS
Calcium antagonists, n (%) 21 (45) 64 (20) 0.001
Table 2 Psychological status in patients with diabetes and
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diabetes, 27 were treated with oral hypoglycemic agents
(OHAs), and seven with insulin either alone or in
combination with OHAs. Participants with diabetes and
IHD had a higher MDI score (more depressive symptoms),
a lower SF-36 physical component summary score, and
a lower score of several sub-measurements of the SF-36
mental component summary score when compared with
patients with IHD but without diabetes (Table 2). No
significant differences were observed regarding stress
measured by the WHO-5 Well-being index, by the number
of CSSs or by the PPS measure (Table 2). No differences in
stress measurements were found between the diabetes
patients on OHAs only vs the insulin treated (PO0.05
for PPS, MDI, SF-36, WHO, and CSS).
ischemic heart disease (IHD) vs IHD alone. Data are expressed as
mean (S.D.).
IHD with
diabetes
(nZ47)
IHD without
diabetes
(nZ314)
P
value
Major Depression Inventorya 11 (7.7) 8.0 (7.0) 0.019
WHO-5 Well-being Index 62 (19) 67 (18) 0.070
SF-36 Quality of life score
Physical component
summary score
45 (10) 49 (8.7) 0.001
Physical functioning 85 (16) 71 (24) !0.001
Role – physical 65 (37) 80 (31) 0.003
Bodily pain 78 (23) 81 (21) 0.326
Mental component
summary score
52 (9.5) 53 (9.8) 0.442
General health 58 (18) 68 (19) 0.001
Vitality 57 (25) 67 (20) 0.004
Social functioning 90 (16) 92 (17) 0.443
Role – emotional 69 (34) 83 (30) 0.004
Mental health 78 (17) 80 (15) 0.264
Pressure pain sensitivity 63 (18) 65 (20) 0.558
Clinical stress signs score 10 (7.6) 8.1 (6.7) 0.073
aBold text means P!0.005.Discussion
This study demonstrates that the combination of diabetes
and chronic and stable IHD seems to be associated with
increased depressive symptoms, lower overall physical
QOL, and reduced mental QOL on several sub-elements
of the questionnaire when compared with patients with
IHD not suffering from known diabetes.
The mean MDI in the Danish general population has
been found to be 7.2 (11). Participants with IHD of this
study had a mean MDI of 8.0 and participants with both
diabetes and IHD an MDI of 11, suggesting a rather large
increase in depressive symptoms in patients suffering from
both chronic diseases. In the Danish general population,
w11% has an MDIR15, suggestive of mild depression. In
this study, this figure was 16% in patients with IHD and
23% in the group with both diabetes and IHD, supporting
the increased burden of depressive symptoms found in
this patient group.http://www.endocrineconnections.org
DOI: 10.1530/EC-14-0083
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Published by Bioscientifica LtdIn the present cohort, 58% had a PPS R60, which is
regarded as a cut-off value for increased chronic stress (8).
This figure was not different in relation to having both
diabetes and IHD vs having only IHD. However, in an
otherwise healthy population, only 27% have been found
to have PPSR60, demonstrating that the present cohort in
fact did show signs of elevated stress, i.e., PPS (9). PPS
measures pain threshold, and reduced pain threshold
(i.e., increased PPS) is observed in several chronic diseases
with a secondary generalized pain sensation such as
fibromyalgia, arthritis, and post-traumatic stress
syndrome (12, 13). Among the sub-items of the physical
SF-36 questionnaire was a question of body pain. This
parameter was not changed due to the presence of
diabetes, and it might be speculated if the reduced score
of overall physical QOL is related not to pain in particular,
but rather to reduced ability of motion in general, as
general stiffness of connective tissue is a well-known
entity of long-standing diabetes (14).
In a recent randomized study with 217 participants
with IHD receiving either treatment as usual or a program
with daily self-measurement of PPS followed by reflection
and action if a high PPS was measured, we found that, after
3 months, the active group, measuring PPS, showed a
significant decrease in both PPS and MDI, suggestive of
lower stress and lower level of depressive symptoms, andThis work is licensed under a Creative Commons
Attribution 3.0 Unported License.
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psychological well-being score, when compared with the
group receiving treatment as usual (10). Overall, the
Cohen’s effect size was 0.12 between the active and
the control groups; however, the effect of the intervention
was consistently more pronounced among the psycho-
logically vulnerable subjects with a Cohen’s effect size of
0.35 among the subjects with MDI R15 (an effect size
similar to the effect of anti-depressive medication) and an
effect size of 0.52 among subjects with both high PPS and
CSSs (10).
A limitation to this study was the much smaller
number of participants in the group with diabetes and IHD
(nZ47) when compared with the group with IHD alone
(nZ314), which should be acknowledged when interpret-
ing the data. However, the groups were large enough to
substantiate a trend toward a more vulnerable psycho-
logical profile among patients suffering from both diabetes
and IHD. Distinction between patients with diabetes
treated with only OHAs and with insulin was hampered
by the small numbers, and the lack of differences between
these groups should be taken with reservation.
Our findings should be acknowledged when dealing
with patients with both diabetes and IHD, i.e., both from a
diabetologist’s and a cardiologist’s perspectives. Based on
our own study with stress intervention in patients with
IHD mentioned above, stress-reducing therapies should be
considered at least in patients with both diabetes and IHD.
This finding might be broadened out to other clinical
situations with combinations of chronic diseases, i.e.,
psychologically vulnerable patients, in which it is known
that QOL is substantially reduced. This clearly calls for
further studies.
In conclusion, this study finds that the combination
of known diabetes and chronic and stable IHD seems to be
associated with increased depressive symptoms, lower
overall physical QOL, reduced mental QOL on several
sub-elements, but not with reduced pain threshold as
measured by PPS. We encourage clinicians to recognize
the double jeopardy with regard to psychological and
especially depressive symptoms when treating patients
with double diagnoses of chronic nature.Declaration of interest
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